• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy.G蛋白偶联受体激酶5在生理性与病理性心肌肥厚中的不同作用
Circ Res. 2015 Dec 4;117(12):1001-12. doi: 10.1161/CIRCRESAHA.115.306961. Epub 2015 Oct 29.
2
GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity.GRK5介导的病理性心脏肥大加剧涉及促进核因子活化T细胞(NFAT)活性。
Circ Res. 2014 Dec 5;115(12):976-85. doi: 10.1161/CIRCRESAHA.116.304475. Epub 2014 Oct 20.
3
Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes.揭示G蛋白偶联受体激酶5作为心肌细胞核中的组蛋白去乙酰化酶激酶。
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12457-62. doi: 10.1073/pnas.0803153105. Epub 2008 Aug 18.
4
Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.确定 G 蛋白偶联受体激酶 5 对病理性心肌肥厚的绝对需求:简短交流。
Circ Res. 2012 Sep 28;111(8):1048-53. doi: 10.1161/CIRCRESAHA.112.273367. Epub 2012 Aug 2.
5
PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy .PH 结构域亮氨酸丰富重复蛋白磷酸酶 2(PHLPP2)调节 G 蛋白偶联受体激酶 5(GRK5)诱导的心肌肥厚。
J Biol Chem. 2018 May 25;293(21):8056-8064. doi: 10.1074/jbc.M117.809913. Epub 2018 Apr 8.
6
A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failure.GRK5 N 端肽可减轻压力超负荷引起的心肌肥厚和心力衰竭。
Sci Signal. 2021 Mar 30;14(676):eabb5968. doi: 10.1126/scisignal.abb5968.
7
Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes.结缔组织生长因子/CCN2 通过诱导心肌细胞中的 G 蛋白偶联受体激酶-5 来减轻β-肾上腺素能受体的反应性和心脏毒性。
Mol Pharmacol. 2013 Sep;84(3):372-83. doi: 10.1124/mol.113.087312. Epub 2013 Jun 18.
8
GRK5 is a regulator of fibroblast activation and cardiac fibrosis.GRK5 是成纤维细胞活化和心脏纤维化的调节因子。
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5). doi: 10.1073/pnas.2012854118.
9
Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart.杂交转基因小鼠揭示了心脏中G蛋白偶联受体激酶的体内特异性。
Circ Res. 2000;86(1):43-50. doi: 10.1161/01.res.86.1.43.
10
G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failure.G 蛋白偶联受体激酶 5(GRK5)参与缺血性心力衰竭后心脏功能障碍和免疫细胞募集。
Cardiovasc Res. 2022 Jan 7;118(1):169-183. doi: 10.1093/cvr/cvab044.

引用本文的文献

1
Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure.替皮法尼布减少细胞外囊泡并预防心力衰竭。
Circ Res. 2024 Jul 5;135(2):280-297. doi: 10.1161/CIRCRESAHA.123.324110. Epub 2024 Jun 7.
2
Insulin-Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II-Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal-Regulated Kinase/Nuclear Factor-κB Pathway.胰岛素样生长因子 1 受体缺乏通过蛋白激酶 B/细胞外信号调节激酶/核因子-κB 通路减轻血管紧张素 II 诱导的心肌纤维化。
J Am Heart Assoc. 2023 Sep 19;12(18):e029631. doi: 10.1161/JAHA.123.029631. Epub 2023 Sep 18.
3
GRK5-mediated inflammation and fibrosis exert cardioprotective effects during the acute phase of myocardial infarction.GRK5 介导热激和纤维化在心肌梗死急性期发挥心脏保护作用。
FEBS Open Bio. 2023 Feb;13(2):380-391. doi: 10.1002/2211-5463.13551. Epub 2023 Jan 20.
4
Cardiomyocyte Cell-Cycle Regulation in Neonatal Large Mammals: Single Nucleus RNA-Sequencing Data Analysis an Artificial-Intelligence-Based Pipeline.新生大型哺乳动物心肌细胞的细胞周期调控:基于人工智能流程的单细胞核RNA测序数据分析
Front Bioeng Biotechnol. 2022 Jul 4;10:914450. doi: 10.3389/fbioe.2022.914450. eCollection 2022.
5
Genetic Catalytic Inactivation of GRK5 Impairs Cardiac Function in Mice Via Dysregulated P53 Levels.GRK5的基因催化失活通过失调的p53水平损害小鼠心脏功能。
JACC Basic Transl Sci. 2022 Mar 9;7(4):366-380. doi: 10.1016/j.jacbts.2022.01.001. eCollection 2022 Apr.
6
Targeting GRK5 for Treating Chronic Degenerative Diseases.靶向 GRK5 治疗慢性退行性疾病。
Int J Mol Sci. 2021 Feb 15;22(4):1920. doi: 10.3390/ijms22041920.
7
GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure.GRK与Epac1在心脏重塑和心力衰竭中的相互作用。
Cells. 2021 Jan 14;10(1):154. doi: 10.3390/cells10010154.
8
KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure.新型GRK5抑制剂KR-39038可减轻心力衰竭中的心肌肥厚并改善心脏功能。
Biomol Ther (Seoul). 2020 Sep 1;28(5):482-489. doi: 10.4062/biomolther.2020.129.
9
A Peptide-Functionalized Magnetic Nanoplatform-Loaded Melatonin for Targeted Amelioration of Fibrosis in Pressure Overload-Induced Cardiac Hypertrophy.一种肽功能化磁性纳米平台负载褪黑素用于压力超负荷诱导的心肌肥厚纤维化的靶向改善。
Int J Nanomedicine. 2020 Feb 27;15:1321-1333. doi: 10.2147/IJN.S235518. eCollection 2020.
10
Long Noncoding RNA Protects Against Cardiac Hypertrophy Through SUZ12 (Suppressor of Zeste 12 Protein Homolog)-Mediated Downregulation of MEF2A (Myocyte Enhancer Factor 2A).长链非编码 RNA 通过 SUZ12(Zeste 12 蛋白同源物抑制因子)介导的 MEF2A(肌细胞增强因子 2A)下调来防止心肌肥厚。
Circ Heart Fail. 2020 Jan;13(1):e006525. doi: 10.1161/CIRCHEARTFAILURE.119.006525. Epub 2020 Jan 20.

本文引用的文献

1
Identification and characterization of amlexanox as a G protein-coupled receptor kinase 5 inhibitor.氨来呫诺作为G蛋白偶联受体激酶5抑制剂的鉴定与表征
Molecules. 2014 Oct 22;19(10):16937-49. doi: 10.3390/molecules191016937.
2
GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity.GRK5介导的病理性心脏肥大加剧涉及促进核因子活化T细胞(NFAT)活性。
Circ Res. 2014 Dec 5;115(12):976-85. doi: 10.1161/CIRCRESAHA.116.304475. Epub 2014 Oct 20.
3
Integration of animal behaviors under stresses with different time courses.整合具有不同时间进程的应激下的动物行为。
Neural Regen Res. 2014 Aug 1;9(15):1464-73. doi: 10.4103/1673-5374.139464.
4
Effects of shear stress pattern and magnitude on mesenchymal transformation and invasion of aortic valve endothelial cells.剪切应力模式和大小对主动脉瓣内皮细胞间充质转化及侵袭的影响
Biotechnol Bioeng. 2014 Nov;111(11):2326-37. doi: 10.1002/bit.25291. Epub 2014 Aug 5.
5
G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism.G 蛋白偶联受体激酶 2:心肌收缩功能与心脏代谢之间的联系。
Circ Res. 2014 May 9;114(10):1661-70. doi: 10.1161/CIRCRESAHA.114.300513.
6
Adrenergic nervous system in heart failure: pathophysiology and therapy.心力衰竭中的肾上腺素能神经系统:病理生理学与治疗。
Circ Res. 2013 Aug 30;113(6):739-53. doi: 10.1161/CIRCRESAHA.113.300308.
7
Nuclear translocation of cardiac G protein-Coupled Receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process.选择的 Gq 激活型肥大配体作用于心脏 G 蛋白偶联受体激酶 5 后可导致其核转位,该过程依赖于钙调蛋白。
PLoS One. 2013;8(3):e57324. doi: 10.1371/journal.pone.0057324. Epub 2013 Mar 5.
8
Signaling effectors underlying pathologic growth and remodeling of the heart.心脏病理性生长和重构的信号效应子。
J Clin Invest. 2013 Jan;123(1):37-45. doi: 10.1172/JCI62839. Epub 2013 Jan 2.
9
Exercise training early after acute myocardial infarction reduces stress-induced hypoperfusion and improves left ventricular function.急性心肌梗死后早期进行运动训练可减少应激诱导的低灌注并改善左心室功能。
Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):315-24. doi: 10.1007/s00259-012-2302-x. Epub 2012 Dec 6.
10
Differential analysis of gene regulation at transcript resolution with RNA-seq.基于 RNA-seq 的转录分辨率下基因调控的差异分析。
Nat Biotechnol. 2013 Jan;31(1):46-53. doi: 10.1038/nbt.2450. Epub 2012 Dec 9.

G蛋白偶联受体激酶5在生理性与病理性心肌肥厚中的不同作用

Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy.

作者信息

Traynham Christopher J, Cannavo Alessandro, Zhou Yan, Vouga Alexandre G, Woodall Benjamin P, Hullmann Jonathan, Ibetti Jessica, Gold Jessica I, Chuprun J Kurt, Gao Erhe, Koch Walter J

机构信息

From the Center for Translational Medicine, Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA (C.J.T., A.C., A.G.V., B.P.W., J.H., J.I., J.I.G., J.K.C., E.G., W.J.K.); and Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA (Y.Z.).

出版信息

Circ Res. 2015 Dec 4;117(12):1001-12. doi: 10.1161/CIRCRESAHA.115.306961. Epub 2015 Oct 29.

DOI:10.1161/CIRCRESAHA.115.306961
PMID:26515328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4825669/
Abstract

RATIONALE

G protein-coupled receptor kinases (GRKs) are dynamic regulators of cellular signaling. GRK5 is highly expressed within myocardium and is upregulated in heart failure. Although GRK5 is a critical regulator of cardiac G protein-coupled receptor signaling, recent data has uncovered noncanonical activity of GRK5 within nuclei that plays a key role in pathological hypertrophy. Targeted cardiac elevation of GRK5 in mice leads to exaggerated hypertrophy and early heart failure after transverse aortic constriction (TAC) because of GRK5 nuclear accumulation.

OBJECTIVE

In this study, we investigated the role of GRK5 in physiological, swimming-induced hypertrophy (SIH).

METHODS AND RESULTS

Cardiac-specific GRK5 transgenic mice and nontransgenic littermate control mice were subjected to a 21-day high-intensity swim protocol (or no swim sham controls). SIH and specific molecular and genetic indices of physiological hypertrophy were assessed, including nuclear localization of GRK5, and compared with TAC. Unlike after TAC, swim-trained transgenic GRK5 and nontransgenic littermate control mice exhibited similar increases in cardiac growth. Mechanistically, SIH did not lead to GRK5 nuclear accumulation, which was confirmed in vitro as insulin-like growth factor-1, a known mediator of physiological hypertrophy, was unable to induce GRK5 nuclear translocation in myocytes. We found specific patterns of altered gene expression between TAC and SIH with GRK5 overexpression. Further, SIH in post-TAC transgenic GRK5 mice was able to preserve cardiac function.

CONCLUSIONS

These data suggest that although nuclear-localized GRK5 is a pathological mediator after stress, this noncanonical nuclear activity of GRK5 is not induced during physiological hypertrophy.

摘要

原理

G蛋白偶联受体激酶(GRKs)是细胞信号传导的动态调节因子。GRK5在心肌中高度表达,且在心力衰竭时上调。尽管GRK5是心脏G蛋白偶联受体信号传导的关键调节因子,但最近的数据揭示了GRK5在细胞核内的非经典活性,其在病理性肥大中起关键作用。由于GRK5的核积累,小鼠心脏中GRK5的靶向升高会导致主动脉缩窄(TAC)后过度肥大和早期心力衰竭。

目的

在本研究中,我们研究了GRK5在生理性游泳诱导肥大(SIH)中的作用。

方法和结果

将心脏特异性GRK5转基因小鼠和非转基因同窝对照小鼠进行为期21天的高强度游泳方案(或无游泳假手术对照)。评估了SIH以及生理性肥大的特定分子和遗传指标,包括GRK5的核定位,并与TAC进行比较。与TAC后不同,经游泳训练的转基因GRK5小鼠和非转基因同窝对照小鼠的心脏生长呈现相似的增加。从机制上讲,SIH不会导致GRK5核积累,这在体外得到证实,因为胰岛素样生长因子-1(一种已知的生理性肥大介质)无法诱导GRK5在心肌细胞中的核转位。我们发现了GRK5过表达时TAC和SIH之间基因表达改变的特定模式。此外,TAC后转基因GRK5小鼠中的SIH能够保留心脏功能。

结论

这些数据表明,尽管核定位的GRK5是应激后的病理介质,但GRK5的这种非经典核活性在生理性肥大过程中不会被诱导。